In contrast, treatment with the GLP-1 receptor agonist liraglutide yielded a small improvement in kidney function at the end of the follow-up period [89], and in two large-scale trials, the use of SGLT2 inhibitors was accompanied by a meaningful and durable improvement in glomerular function and a reduction in the risk of serious adverse renal events [56, 58]
Want to start weight loss consultations with semaglutide
Additionally, Ipamorelin may stimulate muscle growth, although definitive scientific evidence in this area is still pending
Battling Menopausal Weight Gain: Beyond GLP-1 Agonists Written and edited by Sarah Bonza MD, MPH, MSCP, FAAFP, DipABLM, NBC-HWC The menopausal transition brings profound hormonal shifts that often trigger stubborn weight gain, particularly the accumulation of visceral adipose tissue
GLP-1 medications, including semaglutide, tirzepatide, and liraglutide, mimic the natural GLP-1 hormone in your body, which helps control hunger, insulin levels, and fat metabolism